Using Romiplostim to Treat Low Platelet Counts Following Chemotherapy and Autologous Hematopoietic Cell Transplantation in People With Blood Cancer

Conditions:   Multiple Myeloma;   Hodgkin Lymphoma;   Non-Hodgkin Lymphoma;   HDT-AHCT Intervention:   Drug: Romiplostim Sponsors:   Memorial Sloan Kettering Cancer Center;   Amgen Recruiting

Source: ClinicalTrials.gov - July 20, 2020 Category: Research Source Type: clinical trials